Literature DB >> 30279043

Longitudinal trend of global artemisinin research in chemistry subject areas (1983-2017).

Wanqi Xu1, Zhongmei Zou1, Jin Pei2, Linfang Huang3.   

Abstract

Artemisinin, the initial and main drug for malaria prevention and treatment internationally, was first extracted from the plant Artemisia annua L. by Chinese scientists in 1972. Research on artemisinin in chemistry subject areas shows a rapid growth since the 1980s. To evaluate the evolutionary trends and draw the knowledge map of artemisinin research, 1316 relevant publications are analysed based on bibliometrics. The global research status, emerging trends and future directions are also visualised and discussed. Furthermore, a historical overview of chemical synthesis on artemisinin is illustrated via timeline in terms of industrialisation. Overall, this study provides a novel method to visualise further information about artemisinin research and a comprehensive perspective to understand the longitudinal trend over the last 30 years.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atemisinin; Bibliometric analysis; Chemical synthesis; Evolutionary trend; Knowledge map; QingHaoSu

Mesh:

Substances:

Year:  2018        PMID: 30279043     DOI: 10.1016/j.bmc.2018.09.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Artemisia annua L. and photoresponse: from artemisinin accumulation, volatile profile and anatomical modifications to gene expression.

Authors:  Ellen M Lopes; Fábia Guimarães-Dias; Thália do S S Gama; Arthur L Macedo; Alessandra L Valverde; Marcela C de Moraes; Ana Cristina A de Aguiar-Dias; Humberto R Bizzo; Marcio Alves-Ferreira; Eliana S Tavares; Andrea F Macedo
Journal:  Plant Cell Rep       Date:  2019-10-01       Impact factor: 4.570

2.  Worldwide Research Trends on Medicinal Plants.

Authors:  Esther Salmerón-Manzano; Jose Antonio Garrido-Cardenas; Francisco Manzano-Agugliaro
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.